Search results
Results From The WOW.Com Content Network
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
Stryker (NYSE:SYK) has had a great run on the share market with its stock up by a significant 14% over the last three...
Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Stryker's (SYK) third-quarter results are likely to reflect strong segmental performances. ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join.
Most readers would already know that Stryker's (NYSE:SYK) stock increased by 4.9% over the past week. Given that the...